No black box warning on record for Quinapril Hydrochloride/hydrochlorothiazide

As of the latest FDA labeling reviewed, Quinapril Hydrochloride/hydrochlorothiazide (QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Quinapril Hydrochloride/hydrochlorothiazide medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because angiotensin converting inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including quinapril) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema Angioedema of the face, extremities, lips, tongue, g

No black box warning on record for Quinapril Hydrochloride/hydrochlorothiazide

Other warnings & precautions

WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because angiotensin converting inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including quinapril) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema Angioedema of the face, extremities, lips, tongue, g

Quinapril Hydrochloride/hydrochlorothiazide Black Box Warning

No black box warning on record for Quinapril Hydrochloride/hydrochlorothiazide

Other warnings & precautions

Quinapril Hydrochloride/hydrochlorothiazide Black Box Warning

No black box warning on record for Quinapril Hydrochloride/hydrochlorothiazide

Other warnings & precautions